Cambridge Antibody - Directors Shareholding
July 09 1997 - 3:12AM
UK Regulatory
RNS No 1358v
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
DEALINGS BY DIRECTORS
1) NAME OF COMPANY
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2) NAME OF DIRECTOR
SIR AARON KLUG
3) Please state whether notification indicates that it is in
respect of holding of the Director named in 2 above
or holding of that person's spouse or children under
the age of 18 or in respect of a non-beneficial interest
DIRECTOR
4) Name of the registered holder(s) and, if more than
one holder, the number of shares held by each of
them. (If notified)
SIR AARON KLUG
5) Please state whether notification relates to a
person(s) connected with the Director named in 2
above and identify the connected person(s)
DR. ADAM BRIAN JOSEPH KLUG (SON)
DR. DAVID RUPERT KLUG (SON)
6) Please state the nature of the transaction. For
PEP transactions please indicate whether
general/single co PEP and if discretionary/non
discretionary
TRANSFER FOR NO CONSIDERATION FROM SIR AARON KLUG TO
ADAM KLUG - 39,219 SHARES
DAVID KLUG - 39,218 SHARES
7) Number of shares/amount of
stock acquired
N/A
8) ( N/A %)
of issued Class
9) Number of shares/amount
of stock disposed
78,437
10) (0.354%)
of issued Class
11) Class of security
ORDINARY SHARES
12) Price per share
NIL
13) Date of transaction
6 JUNE 1997
14) Date company informed
9 JUNE 1997
15) Total holding following this notification
500
16) Total percentage holding of issued class following
this notification
0.002%
IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE
THE FOLLOWING BOXES
17) Date of grant
N/A
18) Period during which or date on which exercisable
N/A
19) Total amount paid (if any) for grant of the option
N/A
20) Description of shares or debentures involved:
class, number.
N/A
21) Exercise price (if fixed at time of grant) or indication
that price is to be fixed at time of exercise
N/A
22) Total number of shares or debentures over which
options held following this notification
N/A
23) Any additional information
TRANSFEREES HAVE EXECUTED DEEDS OF ADHERENCE
TO DIRECTOR'S LOCK-UP AGREEMENT
24) Name of contact and telephone number for queries
A M NIXON
01763-263233
25) Name and signature of authorised company official
responsible for making this notification
Date of Notification..8 JULY 1997..............................
END
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024